ARCHETYPE General sequencing result parameter (openEHR-EHR-CLUSTER.general_sequencing_result_parameter.v0)

ARCHETYPE IDopenEHR-EHR-CLUSTER.general_sequencing_result_parameter.v0
ConceptGeneral sequencing result parameter
DescriptionGeneral sequencing result parameter.
UseUse to report general sequencing result parameter determined for the genome by a sequencing test. This archetype is meant to be used in the "Test result" SLOT of the Laboratory test result observation archetype.
MisuseNot to be used to report genetic variants, but only general parameters that are determined once per sequencing run.
PurposeTo record general sequencing result parameter of a performed sequencing test.
References
AuthorsNom de l'autor: Aurelie Tomczak
Organització: Institute of Pathology, University Hospital Heidelberg
Correu electrònic: au.tomczak@yahoo.com
Data d'autor original: 2020-07-17
Other Details LanguageNom de l'autor: Aurelie Tomczak
Organització: Institute of Pathology, University Hospital Heidelberg
Correu electrònic: au.tomczak@yahoo.com
Data d'autor original: 2020-07-17
Other Details (Language Independent)
  • Licence: This work is licensed under the Creative Commons Attribution-ShareAlike 4.0 International License. To view a copy of this license, visit http://creativecommons.org/licenses/by-sa/4.0/.
  • Custodian Organisation: HiGHmed
  • Original Namespace: org.openehr
  • Original Publisher: openEHR Foundation
  • Custodian Namespace: org.highmed
  • MD5-CAM-1.0.1: F563A5B83D40B0B5A3126D64A68E49CB
  • Build Uid: de129512-5619-473d-a80a-269b01c57df7
  • Revision: 0.0.1-alpha
KeywordsTumor cell content, BRCAness, Microsatellite instability (MSI), Tumor Mutational Burden (TMB) per Mb, Sequencing result parameter, Whole genome sequencing, Targeted sequencing
Lifecyclein_development
UID662cbae0-6ab8-4ad9-a847-547e69b5c356
Language useden
Citeable Identifier1380.146.160
Revision Number0.0.1-alpha
items
Sequenced tissue typeSequenced tissue type: Normal vs. tumor sample.
Elecció de:
  •  Coded Text
    • Normal tissue [Identifies germline mutations.]
    • Tumor tissue [Identifies somatic mutations.]
  •  Text
Tumor cell content (pathologic/histologic)Tumor cell content (pathologic/histologic): Tumor cell content determinded by pathologic/histologic methods.
Elecció de:
  •  Quantity
    Propietat: Qualified real
    Unitats: %
  •  Proportion
Tumor cell content (bioinformatic)Tumor cell content (bioinformatic): Tumor cell content determinded by bioinformatic methods.
Elecció de:
  •  Proportion
  •  Quantity
    Propietat: Qualified real
    Unitats: %
Microsatellite instability (MSI)Microsatellite instability (MSI): Microsatellite instability (MSI).
Elecció de:
  •  Count
    min: >=0; màx: <=2

  •  Quantity
Tumor Mutational Burden (TMB) per MbTumor Mutational Burden (TMB) per Mb: Tumor Mutational Burden (TMB) per Megabase.
Elecció de:
  •  Count
  •  Quantity
BRCAnessBRCAness: BRCAness is defined as a phenotypic copy of germline BRCA mutations.
min: >=0; màx: <=1

Further result parameterFurther result parameter: Cluster to include additional result parameter not already defined above.
Parameter nameParameter name: Parameter name.
Elecció de:
  •  Text
  •  Coded Text
  •  Identifier
Parameter valueParameter value: Parameter value.
Qualitative parameter interpretationQualitative parameter interpretation: Qualitative parameter interpretation, if applicable.
Other contributors
Translators
  • alemany: Aurelie Tomczak, au.tomczak@yahoo.com, Institute of Pathology, University Hospital Heidelberg